Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Mar 24, 2023; 14(3): 131-137
Published online Mar 24, 2023. doi: 10.5306/wjco.v14.i3.131
Published online Mar 24, 2023. doi: 10.5306/wjco.v14.i3.131
Unusual breast metastasis of gastrointestinal stromal tumor: A case report and literature review
Daria Filonenko, Department of Oncology Chemotherapy, SBIH Moscow Clinical Scientific and Practical Center Named After A.S.Loginov of DHM Moscow, Moscow 111123, Russia
Nikolay Karnaukhov, Department of Pathomorphology, SBIH "Moscow Clinical Scientific and Practical Center Named After A.S. Loginov'' DHM, Moscow 111123, Russia
Gurami Kvetenadze, Department of Surgery, SBIH "Moscow Clinical Scientific and Practical Center Named After A.S. Loginov'' DHM, Moscow 111123, Russia
Lyudmila Zhukova, Department of Oncology, SBIH "Moscow Clinical Scientific and Practical Center Named After A.S. Loginov'' DHM, Moscow 111123, Russia
Author contributions: Filonenko D has been treating the patient, developing the treatment strategy of the patient; made the literature review, analyzed the data and wrote the text of the article and revised the article according to editor’s revisions; Karnaukhov N is pathologist who made the morphology, histology and immunohistochemistry investigations, take a photo of these investigations; Kvetenadze G is a surgeon who performed resection of the right breast; Zhukov L is developing the treatment strategy of the patient, made the literature review, analyzed the data and correct the text of the article and revised the article according to editor’s revisions.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to report.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Daria Filonenko, PhD, Chief Physician, Department of Oncology Chemotherapy, SBIH Moscow Clinical Scientific and Practical Center Named After A.S.Loginov of DHM Moscow, Shosse Enthuziastov 86, Moscow 111123, Russia.
Received: September 21, 2022
Peer-review started: September 21, 2022
First decision: November 14, 2022
Revised: November 27, 2022
Accepted: February 21, 2023
Article in press: February 21, 2023
Published online: March 24, 2023
Processing time: 179 Days and 21.1 Hours
Peer-review started: September 21, 2022
First decision: November 14, 2022
Revised: November 27, 2022
Accepted: February 21, 2023
Article in press: February 21, 2023
Published online: March 24, 2023
Processing time: 179 Days and 21.1 Hours
Core Tip
Core Tip: We presented the second case of gastrointestinal stromal tumor (GIST) metastasis to the breast, which is a very extraordinary condition. The most common metastatic sites of GIST are the liver and the peritoneum and at the same time metastasis to the breast from extramammary carcinomas is extremely rare and in this clinical situation it is obligatory to exclude breast cancer. Our patient received two lines of treatment due to metastatic disease and had a local progression on imatinib and sunitinib therapy, growth only lesion in the breast, we removed increased metastasis (surgery on local progression), that allowed to return to less toxic treatment, the patient resumed imatinib until now.